"MCT enrolls patients, coordinates, and carries out dermatological research studies. By participating in a study, you may have the opportunity to assist us in answering questions and discovering new treatments and techniques to improve dermatological conditions."

During the past decade, MediSearch Clinical Trials conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 22 clinical trials were completed, i.e. on average, 53.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 17 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MediSearch Clinical Trials" #1 sponsor was "Pfizer" with 10 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "AOBiome LLC" with 2 trials sponsored, "Actavis Inc." with 2 trials sponsored and "Cassiopea SpA" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MediSearch Clinical Trials" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "bioRASI, LLC" with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MediSearch Clinical Trials" are "Atopic Dermatitis" (10 trials), "Acne Vulgaris" (5 trials), "Dermatitis, Atopic" (4 trials), "Psoriasis" (4 trials) and "Plaque Psoriasis" (3 trials). Many other conditions were trialed in "MediSearch Clinical Trials" in a lesser frequency.

Most popular intervention types in "MediSearch Clinical Trials" are "Drug" (36 trials), "Biological" (6 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Vehicle" (5 trials), "Lebrikizumab" (4 trials), "PF-04965842 100 mg" (3 trials) and "PF-04965842 200 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "MediSearch Clinical Trials" are 42 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MediSearch Clinical Trials". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in MediSearch Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MediSearch Clinical Trials, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".